chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I contracted COVID-19 on 9SEP2022 and my symptoms were fever, bad cough, aching, and a very bad sore throat. I had congestion as well, I was positive until 16SEP2022.
Chills, body aches, headache, redness and swelling to injection site, and several swollen and painful lymphnodes
patient claims injections given in same arm caused rotator cuff  pain will follow up with mri
I have my left ear completely block, sometimes noises, when People speak with me, and when I speak I feeling like whistle inside my ear.
Rash appeared after approx 24 hrs of vaccine. Looked like fever rash or hives? Itching. Did not appear all over body...both ankles, abdomen, thighs, under armpits, back of knees. It?s been a month and the appearance of the rash is gone, but still experiencing quite a bit of itching at bedtime?
Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Medium, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Shakiness-Mild, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Mild, Additional Details: Patient alerted me that he was feeling unwell, he started hyperventilating, sweating, shaking, experiencing tingling and numbness throughout his body.  Patient was dizziness.  He received an epinephrine shot in which he then layed on the floor and started calming down.  Paramedics came and checked him out and found him to be alert and well.  Patient left store fully recoverd and consulted to go to emergency room if he had any symptoms of an analyphylatic reacction.
Within 2 minutes after receiving the vaccine she began feeling lightheaded, tongue became slightly swollen, feels like she is floating in a dream, feeling a heavy pull down sensation and unable to focus at work as if she had received a high dosage of pain medication.
Swelling and soreness day 1-3, red itchy rash day 3 at injection site-about 2? in diameter
Day after vaccination developed hot spot at site if injection and extreme soreness.  Several days after vaccination noticed an earache on side of vaccination with pain running below ear to shoulder.  Had a spot on head that had pain shooting through it.  Not a full blown headache.  On same side.  Puffiness noted above your left collar bone by neck.  Puffy area soft.  Today 11/30/21 all symptoms resolved except puffy area above left collar bone.  Area size of silver dollar.
low grade fever noon 23jun94; 103.4 R am of 24JUn94; 104.4  R 115PM 24JUN94 seen by MD; 102.0 R PM 24JUN94; 101 R AM 25JUN94; no fever PM 25JUN94;
Diaphoresis, nausea, vomiting. Treated symptomatically all the while with stable vital signs.  Took nourishment, left our facility @ noon then presented again @ 1630 w/ vomiting. Was taken to facility for further evaluation.
I did not have an adverse reaction to the vaccine. On 04/15/2023, a new varicose vein developed and became inflamed. It was very painful. I rested with heat off and on. I also took a blood thinner for 45 days.  As of today, it is mostly resolved.
After receiving the first dose of the Pfizer vaccine (Apr 13 at 11:15AM), I experienced chest aches and pains, difficulty taking a deep breath, heart palpitations severe fatigue, massive headache, and pain in the injection site. The fatigue and headache subsided after a day, the pain at the injection site subsided after three days, and the chest pains began to subside by day 6. Even after day 6, I continued to have radiating pains in my chest, but the difficulty taking a deep breath subsided. For  my second dose (May 04 at 11:15), I experienced severe fatigue, massive headache, and stabbing pains in my chest. These chest pains, I notice at times, caused elevated heart palpitations again, the headache is ongoing two days after the second dose and the chest pains radiate down my arm at times.
Moderna COVID-19 Vaccine EUA. Shot injection site was on left top arm/shoulder.  Time of shot, no issues.  Issue progressed thought out first day and have continued for at least three days.  Tender/soreness in injection site.  Redness, est 1.5 inches diameter around injection site.  Along with itching at injection site.  Itch is not all the time or persistent, comes and goes.  First dose.
Severe rash in my upper body, back and chest; A spontaneous report was received from a Consumer concerning a  78 Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event Rash.    The patient's medical history was not provided. No relevant concomitant medications were reported.    On 2- feb-2021, prior to the onset of the events, the patient received their first of planned dosesof mRNA-1273 (batch:012M20A)  Laboratory details was not provided.   treatment information was provided as amoxicillin.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event is unknown  The reporter assessed the event(s), Rash as  related to study drug.
Redness and edema near injection site (right upper arm) along with itching. Area appx. 8" in length and 3" in width.
06/12/04: Burning itching (use ice to soothe). 06/13/04: Swelling, burning, itching, numbness, pain when breathing, entire arm especially hand. 06/14/04: Same as on 06/13/04 and arm joints aching, intensity increased when lying down at night-breathing ok. 06/15/04: Same as on 06/14/04 but less intensity. Saw physician on 06/16/04-no treatment pt recovered.
Moderna vaccine second dose was administered past it's 12 hour window; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine second dose was administered past it's 12 hour window) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine second dose was administered past it's 12 hour window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine second dose was administered past it's 12 hour window) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. Treatment information was not reported.
Caller took a shower yesterday (1/17) and realized that armpit was swollen. Was concerned, thinking it was breast cancer related.  Tender pain but noticeable swelling. Only on left side where vax was administered.
I had a viable healthy pregnancy by ultrasound on 11/17/09 and I was 6 weeks and 1 day. I had the seasonal flu as well as the H1N1 vaccine on 12/2/09 and on 12/09/09 I had an ultrasound that my baby had died and resulted in a miscarriage. 12/10/09 Medical Records received for DOS 10/06/09. Pt. requesting IUD removal. Desires pregnancy.
Sx forearm swollen/red, local reaction. BENADRYL / heat PRN.
I gave patient second dose of Moderna vaccination about 6:35pm on 6/29/222022.  She came back about 5 minutes later and said she felt dizzy and nauseous.  I had her sit down for 30 minutes.  She got better then started to get worse.  She said her face felt wierd or numb.  She asked if her speech sounded slow.  I then hold her I am going to call 911 for an ambulance to come check her out.  The ambulance came and took her to the hospital.
Within the first 24 hours after vaccination the site was erythema, and swelling with blisters. The swelling continued for 3-4 days.
Within 5-10 minutes of the vaccine I had Tingling in neck, vocal changes, tongue swelling, pins and needles around my neck ear to ear, ear congestion, tongue felt funny, arms and  hands felt like pins and needles, pain in arm that had injection. It took longer than 45 minutes and had to stay 1 1/2 hour before leaving vaccine facility. I had to drink water and it was a much stronger reaction and longer than the first dose . The nurses at the facility  did consider it as an allergy. The next day or two I had a headache and was laying in bed. By the 06/21/2021 I was diagnosed with shingles right in the area I had my surgery for my cancer on my hip which was strange. I am still itching by my tailbone, hip, and upper buttox.
on 9th started with a sore throat.running nose,coughing, by the 12th throat was so sore could hardly swallow. Went to urgent care .Was treated for just a sore throat. Wed 14th in the evening I went into a-fib and ambulance called and taken to hospital. They tried two different meds to get me back to normal sinus rhythm..They sent me home that evening the 15th.Today I`m starting to feel better.
contracted covid after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (contracted covid after the first dose) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical History).    On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 1. On 31-Dec-2020, the patient experienced COVID-19 (contracted covid after the first dose). At the time of the report, COVID-19 (contracted covid after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
COATING OF THE TONGUE itching and tingling  around the mouth feeling warm 'flushing   exam - wnl
A very severe arm ache. Could not move arm for 24 hours. Could finally lay on it on the 4th day. It felt like my arm had been sawed in half by a chain saw!
Headache, NauseaVomiting, chills, fatigue, sleepiness Narrative:
Information has been received from a nurse concerning a 14 year old female patient who on 09-APR-2007 was vaccinated with a first dose of GARDASIL. On 18-JUN-2007 the patient was vaccinated with a second dose of GARDASIL (lot# 657868/0523U). Subsequently the patient experienced leukoplakia.The dentist made the diagnosis and contacted the physician.
arm soreness; Pain in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm soreness) and ARTHRALGIA (Pain in the shoulder) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 027C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (arm soreness) and ARTHRALGIA (Pain in the shoulder). At the time of the report, MYALGIA (arm soreness) and ARTHRALGIA (Pain in the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter.  No treatment medication was provided.   This case was linked to MOD-2021-304608.
was vaccinated with Shingrix, but still got shingles/ suspected vaccination failure; got shingles; This case was reported by a physician via sales rep and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The physician stated that, had a patient who was vaccinated with Shingrix, but still got shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Swelling, erythema cellulitis within 24hours. Erythema spreading. Prescribed Augmentin.
This spontaneous report as received from a licensed practical nurse refers to a 14 year old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was reported. On 13-JUL-2015, the patient was vaccinated with a dose of GARDASIL 9 (dose and route of administration were not reported) that had experienced an excursion. Reporter reported GARDASIL 9 with lot# H021861 which was not valid for GARDASIL 9. However, lot # H021861 (expiration date 09-OCT-2015) was valid for GARDASIL. No adverse reaction was reported. This is one of several reports received form the same reporter. Additional information has been requested.
chills; body aches; dry mouth; Temp 102 within 24hrs/ Fever; dizzy; headache; This is a spontaneous report from a contactable Nurse reporting on behalf of a physician in response to HCP letter sent in a cross-reference case. A 30-year-old female patient received BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; Batch/Lot Number: unknown, expiration date: unknown) via intramuscular route of administration on 21Dec2020 13:00 (at the age of 30-years-old) as Dose 1, 0.3 mL, Single for covid-19 immunization at Workplace Clinic. The patient medical history was not reported, and concomitant medications included Ibuprofen and paracetamol (TYLENOL) both were started from 22Dec2021 to unknown stop date taken for unspecified indication. The patient did not take other vaccinations within 4 weeks prior to vaccination. The patient had no history of previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. On 21Dec2020 at 13:00, the patient experienced Temp 102 within 24hrs, Chills, headache, Dry mouth, dizzy and body aches. Patient was not visit to Emergency Room or Physician Office due to AE reported. The patient was not admitted in hospital. Patient lab test included body temperature with result of Temp 102 within 24hrs on 21Dec2020. NO treatment was given for the adverse events experienced. The outcome of events Temp 102 within 24hrs, Chills, headache and Dry mouth was recovered on an unspecified date in 2021 and outcome of events Dizzy and body aches was unknown. It was reported as Causal Relationship is a reasonable possibility that the event was related to suspect Pfizer product.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
pt recv vax 13MAY96 & 15MAY96 pt noticed rt upper arm where inj was given was hard, swollen, itchy, hot to touch;16MAY96 pt brought sx to RN attention; @ 1530 pt reports less soreness, less itchiness, still edematous, t99.2;
The patient received 3 vaccinations in the following order.  Covid19 in the right arm, then Tdap in the left arm, then Twinrix in the left arm.  Shortly after the Twinrix, the pt stated that she didn't feel well.  Pt stated that she felt faint and wobbly.   Pt was provided a cold compress to place on the back of her neck.  A short period of time later, she felt better and left after making an appointment for her 2nd dose of Twinrix.
diarrhea; she tested positive for Covid-19; she tested positive for Covid-19 with fever; This is a spontaneous report received from a contactable nurse (patient herself). A 42-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number/Expiration date: EK5730/Unknown) via an unspecified route of administration in the left arm on 19Dec2020 and second dose (lot number/expiration date: EL1283/Apr2021) via an unspecified route of administration in the left arm on 07Jan2021 at 18:00 (at the age of 42-year-old) as a single dose for COVID-19 immunization at Hospital. Medical history included ongoing Ulcerative colitis from 1997. Patient prior vaccination included flu shot, had a little neuropathy from the flu shot the last couple of times that she received it and the last flu shot was in 2018. Concomitant medications included adalimumab (HUMIRA) at an unspecified dose once weekly from 2008 still ongoing for Ulcerative colitis and was taking immunosuppressants to treat and rabeprazole sodium (ACIPHEX) at a dose of 20 mg once daily (reported as probably 4 years ago) still ongoing for reflux. Patient was a non-smoker. Patient reported that she works in health care and has a daughter with special needs, and she wanted to protect herself so that she did not become a vector for her daughter, and she was definitely symptomatic for Covid-19 and reported that she ran a fever, her highest temperature was 102.6 and stated that she thinks that it's been coming down considerably every day. On 08Apr2021, patient temperature was 100. On 08Apr2021, patient had COVID-19 PCR test and tested positive after receiving both doses of vaccine. It was unknown that patient had SARS-CoV2 antibodies at diagnosis. On 09Apr2021, her temperature was 99. The patient did not require supplemental oxygen or mechanical ventilation and patient did not have multiorgan failure, respiratory, cardiovascular, vascular, renal, neurological, hematological, dermatological symptoms but had gastrointestinal/hepatic symptoms of diarrhea issues but she has been having ulcerative colitis issues and she would not say that the diarrhea issues started when she got sick. The patient did not receive any additional therapies or initiation of a new medication or other treatment or procedure for Covid-19. The outcome of the event she tested positive for Covid-19 was recovering and for diarrhea was unknown.; Sender's Comments: The contributory role of the suspect product to reported events is possible.
hot red swollen arm from shoulder to elbow -- took antihistamine relief in two days.  Out of town could not see doctor
Dizziness & NauseaVomiting  Narrative: Employee reported immediate side effects of dizziness, nausea, and  shortness of breath to 2nd dose of COVID-19 vaccine. Vital signs taken and were  within normal limits. Reported continued nausea at 1345 while other symptoms  resolved. Multiple nurses offered to call emergency services for employee which  they refused. Patient opted to call Employee Health for further guidance.  Other Relevant History:
Lost consciousness 20 seconds and after 2 min lost con again and EPIPEN given 0.3 mg; Vomiting; Sweating; B/P 140/90.
(L) arm: skin reaction with red raised area 12 cm, with central bullae. (R) arm: raised area.
RASH AND SWELLING TO AREA OF INJECTION WITH PAIN UP TO THE NECK, TINGLING OF ARM. PATIENT REPORTED NECK DISCOMFORT WITH SWELLING OF HER THROAT AND MOUTH.
Approximately 10 minutes post vaccination administration found with no heart beat or respiration. CPR initiated. EMS arrived. received 3 doses of epi. Approximately 20 after EMS arrived ER Dr. called to stop CPR. CPR was stopped. Suddenly heart rhythm noted. CPR restarted and taken to ER. Per hospital report coded again and was admitted to ICU in AFIB. While in ICU coded again but was not resuscitated.
Unclear exposure then fevers 102; Unclear exposure then fevers 102; Myalgia; HA moderate symptoms; Test: Home Ag, Result: Positive; Test: Home Ag, Result: Positive; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A 28 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 25Mar2022, outcome "unknown", COVID-19 (medically significant) with onset 25Mar2022, outcome "not recovered" and all described as "Test: Home Ag, Result: Positive"; EXPOSURE TO SARS-COV-2 (non-serious), PYREXIA (non-serious) all with onset 25Mar2022 02:00, outcome "not recovered" and all described as "Unclear exposure then fevers 102"; MYALGIA (non-serious) with onset 25Mar2022 02:00, outcome "not recovered", described as "Myalgia"; HEADACHE (non-serious) with onset 25Mar2022 02:00, outcome "not recovered", described as "HA moderate symptoms". The patient underwent the following laboratory tests and procedures: body temperature: (25Mar2022) 102; sars-cov-2 test: (25Mar2022) positive, notes: Covid test type post vaccination=Unknown. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19, exposure to sars-cov-2, pyrexia, myalgia, headache. Reporter assessed the case as non-serious. There was no covid prior to vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the current limited available information and the drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events  drug ineffective and covid-19 cannot be excluded.
Fever; Chills; Stomach ache; This case was reported by a consumer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, chills and stomach pain. On an unknown date, the outcome of the fever, chills and stomach pain were unknown.   It was unknown if the reporter considered the fever, chills and stomach pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had fever, chills and stomach pain.